THE TREATMENT OF AMBULATORY ADOLESCENT SCHIZOPHRENIA WITH ACETOPHENAZINE
Abstract
Relative remission was obtained in 72% of adolescents and children having ambulatory schizophrenia when treated with acetophenazine. The great majority were early cases. Due to the fact that the drug is chemically a piperazine phenothiazine jaundice and leukopenia were not factors of undue concern. Pharmacologically the drug resembles aliphatic phenothiazines so that the problem of parkinsonism was reduced in comparison with other piperazines, although the percentage of lethargy was considerably higher than in its chemical analogs.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).